Artiva Biotherapeutics, Inc. (ARTV)
4.20
+0.01
(+0.24%)
USD |
NASDAQ |
Nov 03, 16:00
4.20
0.00 (0.00%)
After-Hours: 18:11
Artiva Biotherapeutics Market Cap : 204.93M for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 204.44M |
| October 30, 2026 | 204.44M |
| October 29, 2026 | 206.39M |
| October 28, 2026 | 208.59M |
| October 27, 2026 | 208.34M |
| October 26, 2026 | 300.56M |
| October 23, 2026 | 300.07M |
| October 22, 2026 | 302.51M |
| October 21, 2026 | 316.66M |
| October 20, 2026 | 320.08M |
| October 19, 2026 | 287.39M |
| October 16, 2026 | 285.44M |
| October 15, 2026 | 295.68M |
| October 14, 2026 | 288.36M |
| October 13, 2026 | 306.90M |
| October 12, 2026 | 330.32M |
| October 09, 2026 | 338.62M |
| October 08, 2026 | 331.79M |
| October 07, 2026 | 341.55M |
| October 06, 2026 | 354.72M |
| October 05, 2026 | 347.89M |
| October 02, 2026 | 333.25M |
| October 01, 2026 | 331.30M |
| September 30, 2026 | 347.40M |
| September 29, 2026 | 343.01M |
| Date | Value |
|---|---|
| September 28, 2026 | 343.99M |
| September 25, 2026 | 341.06M |
| September 24, 2026 | 365.45M |
| September 23, 2026 | 376.68M |
| September 22, 2026 | 394.73M |
| September 21, 2026 | 382.04M |
| September 18, 2026 | 420.10M |
| September 17, 2026 | 411.81M |
| September 16, 2026 | 419.61M |
| September 15, 2026 | 434.74M |
| September 14, 2026 | 494.75M |
| September 11, 2026 | 498.66M |
| September 10, 2026 | 508.42M |
| September 09, 2026 | 526.47M |
| September 08, 2026 | 530.86M |
| September 04, 2026 | 545.99M |
| September 03, 2026 | 542.81M |
| September 02, 2026 | 551.84M |
| September 01, 2026 | 550.38M |
| August 31, 2026 | 551.35M |
| August 28, 2026 | 541.11M |
| August 27, 2026 | 582.58M |
| August 26, 2026 | 574.29M |
| August 25, 2026 | 574.29M |
| August 24, 2026 | 562.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.402B |
| Oncolytics Biotech, Inc. | 47.95M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.958B |
| Anixa Biosciences, Inc. | 105.48M |
Market Cap Related Metrics
| PEG Ratio | -0.1750 |
| Price to Book Value | 0.5897 |
| Price | 4.20 |
| Earnings Yield | -78.86% |
| PEGY Ratio | -0.1750 |